November 2022 PMID 35796695

Nutraceutical Eriocitrin (Eriomin) Reduces Hyperglycemia by Increasing Glucagon-Like Peptide 1 and Downregulates Systemic Inflammation: A Crossover-Randomized Clinical Trial.

Thais Borges Cesar, Fernanda Maria Manzini Ramos, Carolina Barbosa Ribeiro

Full text PDF Download social card

Mentions

Peak: 8 in Jul 2022

across 5 sources since Jul 2022

Extended reach

56,286

potential audience

Total likes

Video views

Mentions per month

Jul 2022 – May 2025

Where it's discussed

News21 articles
X / Twitter8 posts
Reddit2 posts
Blogs2 articles
YouTube1 videos

AI synopsis

What people are saying

These discussions highlight the promising effects of Eriocitrin on blood sugar and inflammation, with participants noting mechanisms like increased GLP-1 levels and reduced inflammatory markers, using words like 'significant,' 'helpful,' and 'potential' to emphasize their positive outlook and interest in the findings.

AgreementModerate agreement

Most discussions acknowledge the positive findings of the study, emphasizing the potential benefits of Eriocitrin for blood sugar control and inflammation reduction.

InterestModerate interest

Participants show moderate interest, discussing the mechanisms like increased GLP-1 and systemic inflammation and sharing enthusiasm about nutraceuticals.

EngagementNeutral engagement

The discussions are somewhat superficial, mostly sharing summaries and tagging related accounts without deep analysis or critique.

ImpactModerate impact

The overall tone suggests that these discussions see the findings as potentially impactful, highlighting the importance of natural compounds in managing health conditions.

Abstract in brief

This study tested the effects of a nutraceutical called Eriomin, which contains the compound Eriocitrin, on blood sugar control and inflammation in people with high blood sugar levels.
Participants took 200mg of Eriomin or a placebo for 12 weeks, then switched after a 2-week washout, and the results showed that Eriomin lowered blood glucose, insulin resistance, certain inflammatory markers, and increased GLP-1, a hormone that helps regulate blood sugar.
Overall, Eriomin helped improve blood sugar management and reduced inflammation in prediabetic and diabetic patients with elevated blood sugar levels.

Read the full abstract

All mentions

Eriocitrin Nutraceutical Enhances Glucose Regulation and Reduces Inflammation

This study tested the effects of Eriomin, containing Eriocitrin, on blood sugar control and inflammation. Participants taking 200mg for 12 weeks showed improved glucose levels, insulin resistance, and increased GLP-1…

Science Students' Showcase · May 2, 2025 65 views

株式会社サンクト

@sanct200301 · X

Jul 31, 2022 · 1 like · 771 followers View post →

Yasuhito SHIMADA (島田康人)

@coboc · X

Nutraceutical Eriocitrin (Eriomin) Reduces Hyperglycemia by Increasing Glucagon-Like Peptide 1 and Downregulates Systemic Inflammation: A Crossover-Randomized Clinical Trial | Journal of Medicinal Food https://t.co/tAobFaZLDW

Jul 14, 2022 · 1,905 followers View post →

DrRPalmquist

@DrPalmquist · X